2021 CMSC Annual Meeting

Tag: 7134DMT71Poster-Disease-modifying TherapyVirginia R. Schobel

Poster-Disease-modifying Therapy

Comparison of Therapy Selection Drivers within the S1P Receptor Modulator and Fumarate Classes Among Multiple Sclerosis Patients Who Recently Switched Treatment

Background: The number of disease-modifying therapies (DMTs) within the S1P receptor modulator and fumarate classes has expanded with...

Read More